Demographic and clinical characteristics of campylobacter bacteremia in children with and without predisposing factors

Pediatric Infectious Disease Journal

Volumn 32, Issue 11, 2013, Pages

  Ben Shimol, Shalom ^a   Carmi, Adi ^a   Greenberg, David ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

bacteremia; Campylobacter; epidemiology; gastroenteritis

Indexed keywords

AMIKACIN; AZITHROMYCIN; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; TETRACYCLINE; TOBRAMYCIN;

AGE DISTRIBUTION; ANTIBIOTIC SENSITIVITY; ARAB; ARTICLE; BACTEREMIA; BETA THALASSEMIA; BILE DUCT ATRESIA; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CAMPYLOBACTER LARI; CAMPYLOBACTERIOSIS; CHILD; CHILDHOOD DISEASE; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DISEASE PREDISPOSITION; FECES CULTURE; FEMALE; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; LEUKEMIA; LEUKOPENIA; LIVER CIRRHOSIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; THROMBOCYTOPENIA; VOMITING; X LINKED AGAMMAGLOBULINEMIA;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ARABS; BACTEREMIA; CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; GASTROENTERITIS; HUMANS; INCIDENCE; INFANT; ISRAEL; MALE; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84886950679     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31829baae0     Document Type: Article

References (22)

1. A llos BM. Campylobacter jejuni Infections: update on emerging issues and trends. Clin Infect Dis. 2001;32:1201-1206.
2. Fernández-Cruz A, Muñoz P, Mohedano R, et al. Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years. Medicine (Baltimore). 2010;89:319-330.
3. Perez N, Heresi GP, Murphy JR. Campylobacter jejeuni. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL, eds. Texbook of Pediatric Infectious Diseases. 6th ed. Volume 1. Philadelphia, PA: Saunders Elsevier; 2009:1709-1724.
4. N ielsen H, Hansen KK, Gradel KO, et al. Bacteraemia as a result of Campylobacter species: a population-based study of epidemiology and clinical risk factors. Clin Microbiol Infect. 2010;16:57-61.
5. A hnen DJ, Brown WR. Campylobacter enteritis in immune-deficient patients. Ann Intern Med. 1982;96:187-188.
6. Pigrau C, Bartolome R, Almirante B, et al. Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns. Clin Infect Dis. 1997;25:1414-1420.
7. R eed RP, Friedland IR, Wegerhoff FO, et al. Campylobacter bacteremia in children. Pediatr Infect Dis J. 1996;15:345-348.
8. Feodoroff B, Lauhio A, Ellstrom P, et al. A Nationwide Study of Campylobacter jejuni and Campylobacter coli bacteremia in Finland over a 10-year period, 1998-2007, with special reference to clinical characteristics and antimicrobial susceptibility. Clin Infect Dis. 2011;53:e99-e106.
9. Skirrow MB, Jones DM, Sutcliffe E, et al. Campylobacter bacteraemia in England and Wales, 1981-91. Epidemiol Infect. 1993;110:567-573.
10. Sakran W, Levin C, Kenes Y, et al. Clinical spectrum of serious bacterial infections among splenectomized patients with hemoglobinopathies in Israel: a 37-year follow-up study. Infection. 2012;40:35-39.
11. Sakran W, Raz R, Levi Y, et al. Campylobacter bacteremia and pneumonia in two splenectomized patients. Eur J Clin Microbiol Infect Dis. 1999;18:496-498.
12. Blaser MJ, Smith PF, Kohler PF. Susceptibility of Campylobacter isolates to the bactericidal activity of human serum. J Infect Dis. 1985;151:227-235.
13. Wassenaar TM, Blaser MJ. Pathophysiology of Campylobacter jejuni infections of humans. Microbes Infect. 1999;1:1023-1033.
14. Manfredi R, Nanetti A, Ferri M, et al. Fatal Campylobacter jejuni bacteraemia in patients with AIDS. J Med Microbiol. 1999;48:601-603.
15. Ben-Shimol S, Dagan R, Givon-Lavi N, et al. Community acquired pneumonia (CAP) in children younger than 5 years of age in southern Israel. Harefuah. 2010;149:137-142, 196.
16. Benifla M, Fraser D, Weizman Z, et al. Epidemiologic characteristics of pediatric emergency room referral and hospitalization for diarrhea in the Negev. Harefuah. 1997;132:534-538, 608.
17. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: 19th Informational Supplement. M100-S19. Wayne, PA: Clinical and Laboratory Standards Institute; 2009.
18. L eibovitz E, Janco J, Piglansky L, et al. Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children. Pediatr Infect Dis J. 2000;19:1060-1067.
19. Central Bureau of Statistics. Statistical Abstract of Israel. No. 62. Jerusalem, Israel: Central Bureau of Statistics; 2011.
20. T ee W, Mijch A. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review. Clin Infect Dis. 1998;26:91-96.
21. Jackson CJ, Fox AJ, Wareing DR, et al. Genotype analysis of human blood isolates of Campylobacter jejuni in England and Wales. Epidemiol Infect. 1997;118:81-89.
22. Schönberg-Norio D, Hänninen ML, Katila ML, et al. Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects. Antimicrob Agents Chemother. 2006;50:1086-1088.